PlexBio CoROCO:6572 67 EV-to-FCF is -5.92 as of Jul. 12, 2026. GuruFocus rates ROCO:6572 with a GF Score™ of 67/100 and a GF Value™ of NT$9.52 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 416 Medical Devices & Instruments companies, PlexBio Co ranks worse than 240384.38% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PlexBio Co's Enterprise Value is NT$470.9 Mil.
PlexBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-79.5 Mil. Therefore, PlexBio Co's EV-to-FCF for today is -5.92.
The historical rank and industry rank for PlexBio Co's EV-to-FCF or its related term are showing as below:
ROCO:6572'
s EV-to-FCF Range Over the Past 10 Years
Min: -96.49 Med: -8.76 Max: -3.28
Current: -5.92
During the past 12 years, the highest EV-to-FCF of PlexBio Co was -3.28. The lowest was -96.49. And the median was -8.76.
ROCO:6572's EV-to-FCF is ranked worse than 100% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs ROCO:6572: -5.92
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PlexBio Co's share price for today is NT$7.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PlexBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-0.602.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PlexBio Co EV-to-FCF Related Terms
PlexBio Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for PlexBio Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PlexBio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PlexBio Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PlexBio Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PlexBio Co's EV-to-FCF falls into.
PlexBio Co's current Enterprise Value is NT$470.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PlexBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-79.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PlexBio Co (ROCO:6572) has a EV-to-FCF of -5.92 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PlexBio Co and its competitors. According to the industry distribution chart, PlexBio Co ranks #999999 out of 416 companies in the Medical Devices & Instruments industry.
Is PlexBio Co's EV-to-FCF too high?
PlexBio Co's current EV-to-FCF is -5.92. Based on the distribution chart, PlexBio Co ranks #999999 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PlexBio Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PlexBio Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PlexBio Co ranks #999999 out of 416 companies for EV-to-FCF. This places PlexBio Co in the lower half of its industry. The industry median EV-to-FCF is 23.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PlexBio Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PlexBio Co's current EV-to-FCF is -5.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PlexBio Co stock overvalued right now?
Based on GuruFocus' analysis, PlexBio Co (ROCO:6572) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$9.52, compared to a current price of NT$7.62 — trading 20% below its estimated fair value. The current EV-to-FCF is -5.92. PlexBio Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PlexBio Co (ROCO:6572), the current EV-to-FCF is -5.92 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PlexBio Co (ROCO:6572) Overvalued in 2026?
Based on GuruFocus' analysis, PlexBio Co stock appears to be undervalued.
The current stock price of NT$7.62 is trading 20% below its estimated GF Value™ of NT$9.52.
GuruFocus considers PlexBio Co to be Modestly Undervalued.
Key valuation signals for ROCO:6572:
EV-to-FCF: -5.92
GF Value™: NT$9.52 vs. price of NT$7.62 (20% below fair value)
No single metric tells the full story. See the ROCO:6572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PlexBio Co Ltd is a Taiwan based company involved in designing, developing and manufacturing IVD products and instrumentations. Its products are used in companion diagnostic panel, early cancer detection screening, prenatal diagnostics and for food and safety testing.
67GF Score
Get the complete analysis for ROCO:6572
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6572 has been successfully added to your 
